三季度资管机构调研热情下降，科技和医药医疗股受青睐

Group 1 - The enthusiasm of asset management institutions for researching listed companies has decreased in the third quarter, with a 24.8% decline in the number of research activities compared to the previous quarter [1][5] - In the second quarter, during a period of market stagnation, asset management institutions increased their research activities by 49.31% [1] - The focus of asset management institutions remains on technology stocks, with a growing interest in pharmaceutical and medical stocks in the third quarter [2][3] Group 2 - Insurance asset management companies conducted a total of 7,687 research activities on 5,850 individual stocks in the first three quarters, with a significant focus on Shenzhen Main Board and Sci-Tech Innovation Board stocks [2] - The most active insurance asset management company was Taikang Asset, which conducted 860 research activities on 566 stocks, primarily on the Shanghai Main Board [2] - The research frequency of brokerage asset management subsidiaries was slightly lower, with 4,216 research activities on 3,321 stocks, showing a preference for high-growth potential and technology-intensive companies [3] Group 3 - Wealth management companies conducted over 2,100 research activities on more than 1,700 listed companies in the first three quarters, with a notable preference for Shenzhen Main Board and Sci-Tech Innovation Board companies [4] - Trust companies showed less enthusiasm compared to other asset management institutions, with 1,580 research activities on 1,337 stocks [4] - The overall investment ratio of wealth management companies in equities remains low, but their management scale reached 27.48 trillion yuan by the end of June [3] Group 4 - The Sci-Tech 50 index rose by 49.02% in the third quarter, significantly outperforming the broader market, with the CSI 300 index increasing by 17.9% [7] - Insurance asset management companies focused on 600 Sci-Tech Innovation Board companies in the third quarter, which, along with Shenzhen Main Board stocks, accounted for 53.57% of their research activities [7] - The most researched stock in the third quarter was Mindray Medical, with 538 institutions conducting research, followed by Huichuan Technology and Maiwei Biological-U [8]